AHS Cancer Control Alberta

Quick facts

Phase 2 pipeline

• Combination Product: Nivolumab with Pemetrexed
• Irinotecan-Capecitabine-Oxaliplatin
• Levothyroxine Oral Tablet [Synthroid]
• Lu-177 DOTA-TATE · Oncology
  Lu-177 DOTA-TATE is a radiolabeled peptide that targets somatostatin receptors on neuroendocrine tumors.

Phase 1 pipeline

• CPERT
• GPERT

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• AHS Cancer Control Alberta portfolio CI brief
• AHS Cancer Control Alberta pipeline updates RSS